| Dr Donald L Helfer Ii, MD | |
|
800 S 3rd St, Montrose, CO 81401-4212 | |
| (970) 249-2211 | |
| Not Available |
| Full Name | Dr Donald L Helfer Ii |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 39 Years |
| Location | 800 S 3rd St, Montrose, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154300523 | NPI | - | NPPES |
| 497642 | Medicaid | AZ | |
| 036079758 | Other | IL | BC OF IL |
| 89081765 | Medicaid | CO | |
| 036079758 | Medicaid | IL | |
| 31657532 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036079758 (Illinois) | Secondary |
| 207L00000X | Anesthesiology | 2014-02368 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dhhs Phs Naihs Shiprock Hospital | 0749193837 | 93 |
News Archive
Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures.
AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.
Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.
› Verified 6 days ago
| Entity Name | Dhhs Phs Naihs Shiprock Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780639971 PECOS PAC ID: 0749193837 Enrollment ID: O20031105000809 |
News Archive
Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures.
AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.
Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald L Helfer Ii, MD Po Box 668, Arvada, CO 80001-0668 Ph: (303) 422-9438 | Dr Donald L Helfer Ii, MD 800 S 3rd St, Montrose, CO 81401-4212 Ph: (970) 249-2211 |
News Archive
Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures.
AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.
Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.
› Verified 6 days ago
Jon R Thurston, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 800 S 3rd St, Montrose, CO 81401 Phone: 970-249-2211 | |
Paul W Rinne, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 S 3rd St, Montrose, CO 81401 Phone: 970-249-2211 | |
Mariovisto F Frogozo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 S 3rd St, Montrose, CO 81401 Phone: 970-249-2211 | |
Mary H Gerodetti, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 800 S 3rd St, Montrose, CO 81401 Phone: 970-249-2211 |